Eli Lilly: An Early Christmas Present Has Just Arrived (Rating Upgrade)
Eli Lilly’s strong position in GLP-1 drugs is overlooked by the market. Find out why LLY stock is a buy even as others pull ...
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...
Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney
Former Wisconsin Rep. Mike Gallagher joined 'America's Newsroom' to discuss Trump's tariff threat against China and his ...
MarketWatch1d
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Eli Lilly Stock Is Rising Tuesday: What's Going On?
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to ...
'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...
Campaign US1d
Chief corporate brand officer Lina Polimeni on Eli Lilly’s ‘big evolution’ in marketing
Eli Lilly and Company chief corporate brand officer Lina Polimeni described the new format as a “big evolution” in the company’s marketing, shifting its focus to the Lilly brand, its patients and an ...
Eli Lilly downgraded to Hold from Buy at Erste Group
Erste Group downgraded Eli Lilly (LLY) to Hold from Buy.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...
GlobalData on MSN23h
MHRA approves Eli Lilly’s Alzheimer’s diagnostic imaging agent Tauvid
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Tauvid (flortaucipir), a diagnostic imaging ...